Skip to Main content Skip to Navigation
New interface
Journal articles

Interleukin‐22 in urinary tract disease – new experimental directions

Molly A Ingersoll 1 Malcolm Starkey 2, 3, * 
* Corresponding author
1 Inflammation et immunité des muqueuses - Mucosal Inflammation and Immunity
Institut Pasteur [Paris], INSERM - Institut National de la Santé et de la Recherche Médicale : U1223
Abstract : Interleukin (IL)-22 is expressed by immune cells in the urinary tract and IL-22 receptor is expressed in urothelium and renal tubule cells. IL-22 can be specifically targeted in the urinary tract or conditionally depleted in mice and targeted therapeutically in humans.
Document type :
Journal articles
Complete list of metadata

Cited literature [14 references]  Display  Hide  Download
Contributor : Marie-Christine Vougny Connect in order to contact the contributor
Submitted on : Wednesday, July 15, 2020 - 2:23:58 PM
Last modification on : Thursday, September 22, 2022 - 6:50:03 PM
Long-term archiving on: : Tuesday, December 1, 2020 - 7:32:12 PM


Interleukin22 in urinary tract...
Publication funded by an institution


Distributed under a Creative Commons Attribution 4.0 International License




Molly A Ingersoll, Malcolm Starkey. Interleukin‐22 in urinary tract disease – new experimental directions. Clinical and Translational Immunology, 2020, 9 (6), pp.e1143. ⟨10.1002/cti2.1143⟩. ⟨pasteur-02899702⟩



Record views


Files downloads